Organization
Australasian Leukaemia and Lymphoma Group
2 clinical trials
Clinical trial
A Trial to Assess the Safety and Efficacy of Epcoritamab-containing Combination Salvage Therapy Followed by Autologous Stem Cell Transplantation and Epcoritamab Consolidation in Patients With Relapsed Large B-cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2026-11-01
Clinical trial
An Open-label, Single-arm, Phase 2 Trial of GlOfitamab anD pIrtobrutinib (LOXo-305) in Patients With Mantle Cell Lymphoma and Prior Exposure to a BTK InhibitorStatus: Recruiting, Estimated PCD: 2032-04-01